(1→ 3)-β-glucan (BDG) testing as an adjunct in the diagnosis of invasive fungal disease
(IFD) has been in use for nearly three decades. While BDG has a very high negative …

Measurement of serum (1→ 3)-β-D-Glucan (BG) is an aid in the diagnosis of fungemia and
deep-seated mycoses, including invasive aspergillosis (IA). BG is present in the cell wall of …

Background. Diagnosis of invasive fungal disease (IFD) is challenging, and it remains a
significant cause of morbidity and mortality in immunocompromised patients. The (1→ 3)-β-d …

Due to limited data on the link between gut barrier defects (leaky gut) and neutrophil
extracellular traps (NETs) in coronavirus disease 2019 (COVID-19), blood samples of …

Despite a well-known association between gut barrier defect (leaky gut) and several
diseases, data on translocation of pathogen molecules, including bacterial DNA (blood …

Nanocellulose, as a native renewable material extracted from cellulosic biomass, has
gained increased attention in biomedical applications due to its unique physical features …

Nanocellulose-based biomaterials for biomedical and pharmaceutical applications have
been extensively explored. However, studies on different levels of impurities in the …

The fungus Aspergillus fumigatus is the main pathogenic agent responsible for invasive
pulmonary aspergillosis. Immunocompromised patients are more likely to develop this …

Pneumocystis jirovecii (carinii) pneumonia (PJP) is a major cause of disease in
immunocompromised individuals. However, until recently no reliable and specific …

Invasive aspergillosis (IA) is an opportunistic infection that is often life threatening in the
immunocompromised host. Early diagnosis is critical, especially given the efficacy and …